Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Precision Surgery for Pheochromocytomas and Paragangliomas.

Wiseman D, Lakis ME, Nilubol N.

Horm Metab Res. 2019 Jul;51(7):470-482. doi: 10.1055/a-0926-3618. Epub 2019 Jul 15.

PMID:
31307109
2.

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma.

Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, Pacak K.

Cancers (Basel). 2019 Jul 3;11(7). pii: E936. doi: 10.3390/cancers11070936. Review.

3.

MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.

Ruff SM, Ayabe RI, Malekzadeh P, Good ML, Wach MM, Gonzales MK, Tirosh A, Nilubol N, Pacak K, Kebebew E, Patel D.

J Surg Res. 2019 May 27;243:1-7. doi: 10.1016/j.jss.2019.04.086. [Epub ahead of print]

PMID:
31146085
4.

ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.

Tirosh A, Killian JK, Zhu YJ, Petersen D, Walling J, Mor-Cohen R, Neychev V, Stevenson H, Keutgen XM, Patel D, Nilubol N, Meltzer P, Kebebew E.

Endocr Pract. 2019 Jun;25(6):580-588. doi: 10.4158/EP-2018-0603. Epub 2019 Mar 13.

PMID:
30865533
5.

The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.

Shell J, Tirosh A, Millo C, Sadowski SM, Assadipour Y, Green P, Patel D, Nilubol N, Kebebew E.

Eur J Radiol. 2019 Mar;112:130-135. doi: 10.1016/j.ejrad.2018.11.023. Epub 2018 Nov 22.

PMID:
30777201
6.

Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?

Babic B, De Roulet A, Volpe A, Nilubol N.

J Endocr Soc. 2018 Dec 12;3(2):304-313. doi: 10.1210/js.2018-00278. eCollection 2019 Feb 1.

7.

Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.

Tirosh A, Mukherjee S, Lack J, Gara SK, Wang S, Quezado MM, Keutgen XM, Wu X, Cam M, Kumar S, Patel D, Nilubol N, Tyagi MV, Kebebew E.

Cancer. 2019 Apr 15;125(8):1247-1257. doi: 10.1002/cncr.31930. Epub 2019 Jan 8.

PMID:
30620390
8.

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure.

Libutti SK, Tamarkin L, Nilubol N.

Oncotarget. 2018 Nov 6;9(87):35723-35725. doi: 10.18632/oncotarget.26267. eCollection 2018 Nov 6.

9.

High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.

Green P, Zagzag J, Patel D, Weinstein LS, Simonds WF, Blau J, Marx S, Kebebew E, Perrier N, Nilubol N.

Surgery. 2019 Jan;165(1):124-128. doi: 10.1016/j.surg.2018.04.064. Epub 2018 Nov 7.

PMID:
30414705
10.

Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.

Boufraqech M, Patel D, Nilubol N, Powers A, King T, Shell J, Lack J, Zhang L, Gara SK, Gunda V, Klubo-Gwiezdzinska J, Kumar S, Fagin J, Knauf J, Parangi S, Venzon D, Quezado M, Kebebew E.

Thyroid. 2019 Jan;29(1):79-92. doi: 10.1089/thy.2018.0424. Epub 2018 Dec 28.

PMID:
30398411
11.

Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.

El Lakis M, Giannakou A, Nockel PJ, Wiseman D, Gara SK, Patel D, Sater ZA, Kushchayeva YY, Klubo-Gwiezdzinska J, Nilubol N, Merino MJ, Kebebew E.

Surgery. 2019 Jan;165(1):50-57. doi: 10.1016/j.surg.2018.05.075. Epub 2018 Oct 14.

12.

Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.

El Lakis M, Gianakou A, Nockel P, Wiseman D, Tirosh A, Quezado MA, Patel D, Nilubol N, Pacak K, Sadowski SM, Kebebew E.

JAMA Surg. 2019 Jan 1;154(1):40-45. doi: 10.1001/jamasurg.2018.3475.

PMID:
30267071
13.

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.

Nilubol N, Boufraqech M, Zhang L, Gaskins K, Shen M, Zhang YQ, Gara SK, Austin CP, Kebebew E.

Oncotarget. 2018 Aug 31;9(68):33030-33042. doi: 10.18632/oncotarget.26050. eCollection 2018 Aug 31.

14.

68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.

Shell J, Keutgen XM, Millo C, Nilubol N, Patel D, Sadowski S, Boufraqech M, Yang L, Merkel R, Atallah C, Herscovitch P, Kebebew E.

Int J Endocr Oncol. 2018 Feb 2;5(1):IJE04. doi: 10.2217/ije-2017-0005. eCollection 2018 Feb.

15.

Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.

Tirosh A, Nilubol N, Patel D, Kebebew E.

Endocr Pract. 2018 Aug;24(8):710-717. doi: 10.4158/EP-2018-0022. Epub 2018 Aug 7.

PMID:
30084688
16.

Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma.

Lo WM, Good ML, Nilubol N, Perrier ND, Patel DT.

Ann Surg Oncol. 2018 Sep;25(9):2535-2540. doi: 10.1245/s10434-018-6559-6. Epub 2018 Jul 3.

PMID:
29971678
17.

Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection.

Nockel P, Tirosh A, El Lakis M, Gaitanidis A, Merkel R, Patel D, Nilubol N, Sadowski SM, Cochran C, Gorden P, Kebebew E.

Endocrine. 2018 Sep;61(3):422-427. doi: 10.1007/s12020-018-1633-1. Epub 2018 Jun 19.

PMID:
29923016
18.

Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.

Nilubol N, Yuan Z, Paciotti GF, Tamarkin L, Sanchez C, Gaskins K, Freedman EM, Cao S, Zhao J, Kingston DGI, Libutti SK, Kebebew E.

J Natl Cancer Inst. 2018 Sep 1;110(9):1019-1029. doi: 10.1093/jnci/djy003.

19.

Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.

El Lakis M, Nockel P, Gaitanidis A, Guan B, Agarwal S, Welch J, Simonds WF, Weinstein L, Marx S, Nilubol N, Patel D, Merkel R, Tirosh A, Kebebew E.

J Am Coll Surg. 2018 May;226(5):933-938. doi: 10.1016/j.jamcollsurg.2018.01.007. Epub 2018 Mar 2.

20.

Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.

Nockel P, El Lakis M, Gaitanidis A, Merkel R, Patel D, Nilubol N, Prodanov T, Pacak K, Kebebew E.

Ann Surg. 2019 Apr;269(4):741-747. doi: 10.1097/SLA.0000000000002671.

PMID:
29334561

Supplemental Content

Loading ...
Support Center